Teva Pharmaceutical Industries Ltd. Will present at the Leerink Partners Global Healthcare Conference on March 9, 2026, the company announced today.
The presentation is scheduled for 10:00 AM, according to a statement released by Teva. The conference will be held as Teva navigates a complex pharmaceutical landscape, including ongoing scrutiny of generic drug pricing and competition from biosimilars.
Teva’s participation in the Leerink Partners conference follows a recent announcement that the company will also present at the Barclays Global Healthcare Conference in March. This marks a key period for investor engagement as Teva continues to implement its strategic priorities.
The company, traded on both the New York Stock Exchange (NYSE) and the Tel Aviv Stock Exchange (TASE), is closely watched by investors interested in the global healthcare sector. The Leerink Partners event provides a platform for Teva to share updates on its pipeline, financial performance, and strategic outlook.
Details regarding access to the presentation, including webcast information, have not yet been disclosed. Teva’s investor relations website will be updated with further information as it becomes available.
